S059 Coding and Documentation
DESCRIPTION
Speakers in this session review key elements of coding and documentation relevant to the day-to-day practice of clinical dermatologists. Recent or imminent changes in rules and regulations are highlighted. Adequate time is available for numerous questions from the audience. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuing Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org
LEARNING OBJECTIVES
Code E/M visits and procedures correctly.
Apply current rules and guidelines to ensure that chart documentation accurately conveys what occurred and is also adequate to support the codes selected.
Describe recent and impending changes in coding and documentation guidelines.
SCHEDULE
9:00 AM
Mastering Modifiers: Boost Accuracy and Eliminate Coding Errors
Kishwer S. Nehal, MD, FAAD
9:20 AM
Cracking the Code: Mastering E/M Levels for Accurate Service Reporting
Alexandra Flamm, MD, FAAD
9:40 AM
Navigating Surgical Complications: Accurate Coding for Better Claim Outcomes
Alexander Miller, MD, FAAD
10:00 AM
Tackling Top Payer Challenges: Latest Updates in documentation requirements that impact coding and reimbursement
Margaret (Molly) Moye, MD, FAAD
10:20 AM
Bridging the Gap: Effective Communication strategies that enhance patient care
Aaron Solomon Farberg, MD, FAAD
10:40 AM
Q&A
DIRECTOR
Murad Alam, MD, FAAD
SPEAKERS
Aaron Solomon Farberg, MD, FAAD
Alexandra Flamm, MD, FAAD
Alexander Miller, MD, FAAD
Margaret (Molly) Moye, MD, FAAD
Kishwer S. Nehal, MD, FAAD
DISCLOSURES
Murad Alam, MD, FAAD
No financial relationships exist with ineligible companies.
Aaron Solomon Farberg, MD, FAAD
AbbVie – Advisory Board(Honoraria); Almirall – Advisory Board(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Castle Biosciences – Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Galderma Global – Advisory Board(Honoraria); Incyte – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria);
Alexandra Flamm, MD, FAAD
No financial relationships exist with ineligible companies.
Alexander Miller, MD, FAAD
No financial relationships exist with ineligible companies.
Margaret (Molly) Moye, MD, FAAD
Forefront Dermatology – Advisory Board(Stock Options), Employee (w-2 relationship)(Salary), Stockholder(Stock);
Kishwer S. Nehal, MD, FAAD
No financial relationships exist with ineligible companies.